|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II study of suni- tinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘 | Burstein H J Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 2 | Neoadjuvant therapy for surgically staged ⅢA N2 no small cell lung cancer显示文摘 | Elias AD Skarin AT Leong T | 1997 | Lung Cancer1997，17，1： | 1 |
| 3 | Phase II study of sunitinib malate,an oral multitargeted tyrosine kinase inhibitor,in patients with metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘 | Burstein H J Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 4 | A phase II trial of peme- trexed and gemeitabine in patients with metastatic breast cancer who have received prior taxane therapy显示文摘 | Pippen J Elias AD Neubauer M | 2010 | Clin Breast Cancer2010，10，2： | 1 |
| 5 | Phase II study of sanitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘 | BURSTEIN HJ ELIAS AD RUGO HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 6 | Phase Ⅱ study of sunitinib malate,an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracyeline and a taxane显示文摘 | Burstein HJ Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 7 | Phase II study of sunitinib malate, an oral muhitargeted tyrosine kinase inhibitor, inpatients with metastatic breast cancer previously treated with an anthracycline and ataxane显示文摘 | Burstein H J Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，： | 1 |
| 8 | Autologous stem cell transplantation for small cell lung cancer显示文摘 | Elias AD Stiff PJ | 2002 | Biol Blood Marrow Transplant2002，8，5： | 1 |
| 9 | PhaseⅡstudy of Sunitinibmalate,an oral multitargeted tyrosine kinase inhibitor,in patientswith metastatic breast cancer previously treated with an anthracy-cline and a taxane显示文摘 | Burstein HJ Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 10 | Triple-negtive breast cancer:a short review显示文摘 | Elias AD | | 0，，06： | 1 |
| 11 | Phase Ⅱ study of sunitinib malate,an oral multitargeted tyrosine kinase inhibitor,in patients with metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘 | Burstein H J Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 12 | Small cell lung cancer:state-of-the-art therapy in 1996显示文摘 | Elias AD | 1997 | Chest1997，112，4： | 1 |
| 13 | Phase Ⅱ study of sunitinib malate,an oral multitargeted tyrosine kinase inhibitor,in patients with metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘 | Burstein HJ Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，： | 1 |
| 14 | Autologous stem cell transplantation for small cell lung cancer显示文摘 | Rizzo JD Elias AD Stiff PJ | 2002 | Biol Blood Marrow Transplant2002，8，5： | 1 |
| 15 | Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane显示文摘 | Burstein HJ Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，： | 1 |
| 16 | Phase Ⅱ study of SU11248, a multitargeted receptor tyrosine kinase inhibitor ( TKI), in patients (pts) with previously treated metastatic breast cancer (MBC) 显示文摘 | Miller KD Burstein HJ Elias AD | 2005 | Breast Cancer Res and Treat2005，94，1： | 1 |
| 17 | Phase Ⅱ study of sunitinib malate, an oral muhitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane 显示文摘 | Burstein H J Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，11： | 1 |
| 18 | Treatment of severe veno-occlusive disease with defibrotide:compassionate use results in response without significant toxicity in a high-risk population 显示文摘 | Richardson PG Elias AD Krislman A | 1998 | Blond1998，92，3： | 1 |
| 19 | Phase II study of sunitinibmalate, an oral multi targeted tyrosine kinase inhibitor, in patientswith metastatic breast cancer previously treated with an anthracy-cline and taxanel显示文摘 | Burstein HJ Elias AD Rugo HS | 2008 | J Clin Oncol2008，26，： | 1 |
| 20 | A phase Ⅱ trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy显示文摘 | Pippen J Elias AD Neubauer M | 2010 | Clin Breast Cancer2010，10，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员